Danone Buys Wockhardt's Nutrition Brands That Abbott Won Then Lost
This article was originally published in The Tan Sheet
Executive Summary
After several months of discussions, debt-laden Indian drug maker Wockhardt Ltd. managed to sell its growing nutritional business to French food giant Group Danone for a reported $354 million
You may also be interested in...
Emerging Markets Compound Stagnation In Developed Economies
The rapid growth of emerging markets – key regions for many OTC firms – is a major contributor to the industrialized world’s economic stagnation, an HSBC analyst says. Emerging market growth hinders recovery in developed markets by driving up commodity and oil costs, breaking the link in the traditional boom-bust economic cycle.
Emerging Markets Compound Stagnation In Developed Economies
The rapid growth of emerging markets – key regions for many OTC firms – is a major contributor to the industrialized world’s economic stagnation, an HSBC analyst says. Emerging market growth hinders recovery in developed markets by driving up commodity and oil costs, breaking the link in the traditional boom-bust economic cycle.
Signs Point To Abbott Joint Venture With India’s Biocon
India-based Biocon’s collaborative research arm Syngene, known for its research partnerships with a large set of global companies, likely will develop products up to a certain stage based on leads Abbott provides. Industry sources say they expect Abbott and Biocon are in advanced discussions.